XML 160 R41.htm IDEA: XBRL DOCUMENT
v3.25.3

Stockholders' Deficit (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2025 | Dec. 31, 2024
Stockholders' Equity Note [Abstract] |  |
Schedule of Common Stock Reserved For Future Issuance | Common stock reserved for future issuance as of September 30, 2025 was as follows (in thousands).
|  | September 30, 2025 |
Earn Out Securities |  |  | 74,998 |
Common stock warrants 1 |  |  | 65,235 |
Outstanding stock options |  |  | 55,990 |
Shares available for issuance under equity incentive plan |  |  | 28,195 |
Cumulative redeemable convertible preferred stock |  |  | 14,216 |
Sponsor Earn Out Securities |  |  | 6,250 |
Shares available for issuance under the ESPP |  |  | 5,639 |
Total |  |  | 250,523 |
1 Common stock warrants include both equity-classified and liability-classified warrants (see Note 9). |
| The Company has the following shares of common stock reserved for future issuance, on an as-if converted basis (in thousands):
|  | December 31, 2024 |
Redeemable convertible preferred stock |  |  | 93,963 |
Outstanding stock options |  |  | 74,211 |
Shares available for issuance under equity incentive plan |  |  | 2,175 |
Redeemable convertible preferred stock warrants |  |  | 1,969 |
Common stock warrants |  |  | 1,433 |
Total |  |  | 173,751 |
Schedule of Common Stock Warrants | As of September 30, 2025, the Company had the following equity-classified common stock warrants outstanding (in thousands, except exercise price per share):
|  | Shares Underlying Warrants |  |  | Exercise Price Per Share |  |  | Expiration Date |
Public Warrants |  |  | 25,000 |  |  | $ | 11.50 |  |  |  | 9/24/2030 |
Private Placement Warrants |  |  | 14,300 |  |  | $ | 11.50 |  |  |  | 9/24/2030 |
Assumed Kodiak Warrants |  |  | 559 |  |  | $ | 2.24 |  |  |  | 12/31/2028, 6/30/2031 |
Total outstanding |  |  | 39,859 |  |  |  |  |  |  |  |  |
| The Company has issued common stock warrants in connection with entering into advisory and services agreements as well as debt arrangements. As of December 31, 2024, outstanding warrants to purchase the Company’s common stock were as follows, which all met the conditions for equity classification (in thousands, except price per share):
|  | Shares Underlying Warrants |  |  | Exercise Price Per Share |  |  | Expiration Date
Warrants issued with debt arrangement |  |  | 168 |  |  | $ | 0.34 |  |  | January 2029
Warrants issued with advisory agreement |  |  | 1,167 |  |  | $ | 0.01 |  |  | March 2026
Warrants issued with 2022 Equipment Facility |  |  | 46 |  |  | $ | 0.84 |  |  | July 2032
Warrants issued with services agreement |  |  | 52 |  |  | $ | 0.01 |  |  | February 2025 and 2026
Total outstanding |  |  | 1,433 |  |  |  |  |  |  |

X
- Definition Schedule of common stock reserved for future issuance. + References No definition available. + Details
Name: | kdk_ScheduleOfCommonStockReservedForFutureIssuance
Namespace Prefix: | kdk_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration